Stocks and Investing Stocks and Investing
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Swayampakula Ramakanth Maintained (XFOR) at Strong Buy with Decreased Target to $8.5 on, May 13th, 2022


Published on 2024-10-27 21:04:57 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $11 to $8.5 on, May 13th, 2022.

Swayampakula has made no other calls on XFOR in the last 4 months.



There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, April 5th, 2022